Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheet (Parenthetical)

v3.21.2
Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Millions
Jun. 30, 2021
Dec. 31, 2020
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell measured at fair value $ 163,344 $ 108,856
Trading account assets, pledged as collateral 114,268 91,510
Debt securities:    
Fair Value 650,025 448,180
Loans and leases, measured at fair value 6,950 6,681
Loans held for sale, measured at fair value 2,207 1,585
Other assets, measured at fair value 14,928 15,718
Deposits in U.S. offices:    
Interest bearing, measured at fair value 515 481
Federal funds purchased and securities loaned or sold under agreements to repurchase 165,781 135,391
Short-term borrowings, measured at fair value 4,490 5,874
Accrued expenses and other liabilities, measured at fair value 15,174 16,311
Accrued expenses and other liabilities, reserve for unfunded lending commitments 1,687 1,878
Long-term debt, measured at fair value $ 30,361 $ 32,200
Shareholders’ equity    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 3,887,686 3,931,440
Preferred stock outstanding (in shares) 3,887,686 3,931,440
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 12,800,000,000 12,800,000,000
Common stock issued (in shares) 8,487,151,465 8,650,814,105
Common stock outstanding (in shares) 8,487,151,465 8,650,814,105
Short-term borrowings | Consolidated VIEs    
Shareholders’ equity    
Non-recourse debt $ 37 $ 22
Long-term debt | Consolidated VIEs    
Shareholders’ equity    
Non-recourse debt 5,137 7,053
Other liabilities | Consolidated VIEs    
Shareholders’ equity    
Non-recourse debt $ 15 $ 16